TREATMENT OUTCOMES OF PROLONGED INDUCTION OR RE-ESCALATION DOSING OF UPADACITINIB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Annadurai, Vasantham
Axenfeld, Ellen
Faye, Adam S.
Axelrad, Jordan E.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1859
引用
收藏
页码：S1147 / S1147
页数：1
相关论文
共 50 条
  • [41] Adherence to treatment in patients with inflammatory bowel disease
    Andreev, K. A.
    Gorbenko, A., V
    Skirdenko, Yu. P.
    Nikolaev, N. A.
    Livzan, M. A.
    Bikbavova, G. R.
    Fedorin, M. M.
    BYULLETEN SIBIRSKOY MEDITSINY, 2021, 20 (03): : 120 - 128
  • [42] Psychological Treatment of Patients with Inflammatory Bowel Disease
    Huguet, Jose Maria
    Ruiz, Lucia
    Latorre, Mercedes
    Carbajo, Eva
    Gallego, Ana Monzo
    Suarez, Patricia
    Rodriguez, Isabel
    Tome, Alicia
    Chulia, Enrique Medina
    GASTROENTEROLOGY, 2009, 136 (05) : A658 - A658
  • [43] THE EFFECT OF INFLIXIMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTIBODIES TO INFLIXIMAB
    Tun, Gloria S. Z.
    Marshall, Laura
    Thompson, Laura
    Campbell, Rebecca
    Hale, Melissa F.
    Chew, Thean S.
    Brooks, Alenka J.
    Robinson, Kerry
    Lobo, Alan J.
    GUT, 2019, 68 : A61 - A62
  • [44] De-escalation of Combination Drug Therapy in Inflammatory Bowel Disease Patients
    Saleh, Adam A.
    Waghela, Rajdeepsingh
    Garza, Manuel
    Stading, Rachel
    Miroballi, Natalia
    Moskow, Joshua
    Thurston, Theresa
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S722 - S722
  • [45] Treatment adherence in patients with inflammatory bowel disease
    Patil, S.
    Bhatt, J.
    Deshmukh, A.
    Ingle, M.
    Joshi, A.
    Abraham, P.
    Desai, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A107 - A107
  • [46] EFFECT OF VEDOLIZUMAB DOSE ESCALATION ON RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    GASTROENTEROLOGY, 2017, 152 (05) : S77 - S77
  • [47] Vedolizumab dose escalation as a way of recapturing response in patients with inflammatory bowel disease
    Sierra Morales, M.
    Birdi, S.
    Samaan, M. A.
    Brown-Clarke, C.
    Duncan, J.
    Stanton, A.
    Koumoutsos, I.
    Anderson, S.
    Ray, S.
    Mawdsley, J.
    Sanderson, J.
    Irving, P. M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S451 - S452
  • [48] The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab
    Tun, Gloria S. Z.
    Robinson, Kerry
    Marshall, Laura
    Wright, Alison
    Thompson, Laura
    Wild, Graeme
    Sargur, Ravishankar
    Brooks, Alenka J.
    Hale, Melissa F.
    Chew, Thean S.
    Lobo, Alan J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (03) : 295 - 301
  • [49] Psychological treatment for patients with inflammatory bowel disease
    Jose Leiva, Maria
    REVISTA MEDICA CLINICA LAS CONDES, 2019, 30 (05): : 365 - 371
  • [50] Telemedicine in the treatment of patients with inflammatory bowel disease
    Aguas, Mariam
    Del Hoyo, Javier
    Faubel, Raquel
    Vatdivieso, Bernardo
    Nos, Pilar
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (09): : 641 - 647
12345